BIIB News 306.20 04/22/2014 17:26:43 Biogen Idec Inc (BIIB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biogen Idec Inc (BIIB) 306.20 $BIIB

A Drill Can Help Identify Right Time To Sell Leaders
at Investor's Business Daily - 15 mins ago
When leading stocks fall, you need to read the situation impartially. However, if you have a position in a top stock from a top group, emotions can cloud judgment. You might sell in fear, or you might hold firm in stubbornness. A drill is the best...

Stocks Rise In Higher Volume; Gilead Up After Hours
at Investor's Business Daily - 1 hr 11 mins ago
Stocks rose in higher volume Tuesday, with the Nasdaq and S&P 500 notching their sixth straight gains amid a flurry of buyout activity in the drugs industry. The Nasdaq rose 1%, while the S&P 500 and the Dow Jones industrial average each rose 0.4%....

Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 41 mins ago
Sarepta shares soared over 39% after the company announced it would submit a NDA for eteplirsen by year end.

Biotech Earnings Preview
Brian Orelli, The Motley Fool - Motley Fool - Tue Apr 22, 1:00PM CDT
It's Fools' favorite time of the year: earnings season. In the video below, senior biotech specialist Brian Orelli and health-care bureau chief Max Macaluso discuss a few biotechs that will release first quarter earnings shortly. Gilead Sciences...

Keep an Eye on these 3 Biotech Stocks - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 10:49AM CDT
This sell-off was more due to a change in sentiment rather than a shift in industry fundamentals.

Alexion Likely to Keep Earnings Streak Alive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 10:00AM CDT
Alexion is set to report first quarter 2014 results before the opening bell on Apr 24.

Insider Trading Alert - BIIB, JAZZ And KWK Traded By Insiders
at The Street - Tue Apr 22, 9:15AM CDT
Stocks with insider trader activity include BIIB, JAZZ and KWK

Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 8:39AM CDT
Cytokinetics, Incorporated was a big mover last session, as its shares rose nearly 14% on the day.

Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 7:51AM CDT
Sarepta Therapeutics, Inc. was a big mover last session, as its shares rose over 39% on the day.

ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 7:44AM CDT
ANI Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares surge nearly 21% on the day.

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 7:41AM CDT
Retrophin (RTRX) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter as well as the current year.

Biogen Idec enters into license agreement with Amunix for XTENylated Factor VIII
M2 - Tue Apr 22, 6:49AM CDT
US based biotechnology company Amunix Operating disclosed on Monday that Biogen Idec (NASDAQ:BIIB) has exercised its option to sign an exclusive, worldwide license agreement to research and develop novel, fully-recombinant Factor VIII products with improved therapeutic properties.

What to Watch for in Biotech Earnings This Week
George Budwell, The Motley Fool - Motley Fool - Mon Apr 21, 5:30PM CDT
Biotech stocks started the year off on a tear but have moved lower lately in dramatic fashion. For instance, the iShares Nasdaq Biotech Index is now down over 2% for the year, after gaining double digits at one point in early February. Pundits and...

Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 5:20PM CDT
Amgen has an Earnings ESP of 0.00% with a Zacks Rank #1 (Strong Buy).

Look for Shares of Biogen Idec to Potentially Pullback after Yesterday's 2.56% Rise
Comtex SmarTrend(R) - Mon Apr 21, 4:12PM CDT
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $290.20 to a high of $298.57. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $296.00 on volume of 981,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 2.56% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Apr 21, 4:11PM CDT
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $290.20 to a high of $298.57. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $296.00 on volume of 981,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 9:50AM CDT
Gilead is set to report first quarter 2014 results on Apr 22 after the market closes

Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII
Marketwire - Mon Apr 21, 7:02AM CDT
Amunix Operating Inc. announced today that Biogen Idec (NASDAQ: BIIB) has exercised its option to enter into an exclusive, worldwide license agreement to research and develop novel, fully-recombinant Factor VIII products with improved therapeutic properties. Under the terms of the option agreement, Amunix will receive an upfront $1 million payment and will also be eligible to receive up to $38 million in clinical and commercial milestone payments. In addition, royalties will be paid on commercial sales by Biogen Idec for Factor VIII products incorporating Amunix proprietary XTEN technology.

Meet the Company That's Changing the Multiple Sclerosis Treatment Landscape
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 19, 1:05PM CDT
Here at The Motley Fool we spend a lot of time dissecting companies at the leading edge of the largest investment opportunities. Being a specialist in the Health Care sector, that means I devote a lot of my research to drugs aimed at treating some of...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

California Stone Ban Puts a Hidden Worker Toll in View

Updated Category News Views 42

Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....

Continue Reading
Water Damage Coverage Has More Traps Than Homeowners Think

Updated Category News Views 29

A wet basement does not care one bit whether the water arrived dramatically or dripped in for months. That ugly distinction, though, can decide whether a homeowner has an insurance claim or a repair bill that lands with a thud. Kathy Thurmond-Edwards, an insurance expert in Memphis, Tennessee, lays out the dividing lines plainly: sudden pipe failures may be treated very...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 68

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Surf City Seasons Put Vacation Rental Timing in Focus

Updated Category News Views 28

Summer’s Calendar Does the Talking School bells, not seagulls, appear to set the pace for Surf City’s rental market. Chris Rackley’s seasonal guide makes a pretty grounded point: the “best” time to visit Surf City, North Carolina, is not some universal magic week on a postcard. It depends on whether a traveler needs peak beach weather, wants elbow room, or...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 71

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 73

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 110

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 61

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading

Top 5 Most Recently Viewed Articles

Organon & Co. Class Action Lawsuit: Key Details You Should Know

Updated Category News Views 221

Overview of the Class Action Lawsuit Against Organon & Co. The latest developments in the class action lawsuit regarding Organon & Co. (NYSE: OGN) have attracted attention from investors. The lawsuit is aimed at representing purchasers of Organon's publicly traded securities during a specific time frame. Robbins Geller Rudman & Dowd LLP has taken the lead in filing this...

Continue Reading
JINRO Partners with BTS's V: A Strategic Move

Updated Category News Views 25

What's Brewing Between JINRO and BTS's V? Picture this: you're wandering the aisles of an international market, see a splashy new bottle of soju, and notice V from BTS smiling from the label. That's right, folks, JINRO, the world's reigning soju brand, has just snagged a partnership with BTS's V to serve up a global brand punch. This move isn't just a pretty face on a...

Continue Reading
Latin Metals Unveils Exciting Spin-Out Plan for Copper Assets

Updated Category News Views 172

Latin Metals Moves Forward with Spin-Out of Peruvian Assets Latin Metals Inc. (TSXV: LMS, OTCQB: LMSQF) is charting a new course by announcing its decision to spin-out certain Peruvian exploration projects into a newly founded subsidiary named Latin Explore. This strategic move aims to unlock value for shareholders while maintaining a robust exploration agenda. Overview...

Continue Reading
McCormick's Resilience Shines Amidst Economic Challenges

Updated Category News Views 66

McCormick Challenges and Growth Strategy McCormick & Company, Inc. (NASDAQ: MKC) recently announced its third-quarter earnings, revealing a solid financial performance, even in a tough consumer environment. The company achieved a 1% volume growth in its Consumer segment and steady sales in its Flavor Solutions segment, showcasing a strong market presence despite...

Continue Reading
Goodyear's Financial Performance Amidst Industry Challenges

Updated Category News Views 248

Understanding Goodyear's Recent Earnings Report Goodyear Tire & Rubber Co (NASDAQ: GT) has reported its recent financial results, particularly highlighting the challenges faced during the second quarter of their fiscal year 2025. This period proved to be quite turbulent after the closing bell, reflecting considerable disruptions in their operating environment that...

Continue Reading